PRESS RELEASE published on 01/29/2024 at 22:10, 2 years 8 months ago EQS-Adhoc: Formycon resolves on cash capital increase of EUR 82.84 million – all new shares were subscribed by Gedeon Richter as new strategic investor Formycon AG resolves on EUR 82.84 million cash capital increase by issuing 1,603,877 new shares, all subscribed by Gedeon Richter as strategic investor. Proceeds for biosimilar pipeline development. New shares to be traded on Frankfurt Stock Exchange Frankfurt Stock Exchange Formycon AG Cash Capital Increase Gedeon Richter Biosimilar Pipeline
PRESS RELEASE published on 11/10/2023 at 06:30, 2 years 10 months ago Formycon hosts conference call on nine-month figures 2023 and presents at further investor conferences
PRESS RELEASE published on 10/10/2023 at 07:30, 2 years 11 months ago Formycon Ranibizumab Biosimilar FYB201/CIMERLI®1 achieved 25% market share2 in the United States
PRESS RELEASE published on 09/29/2023 at 07:30, 3 years ago Formycon and Fresenius Kabi announce European Medicines Agency Submission Acceptance of the Marketing Authorization Application for FYB202, an Ustekinumab Biosimilar Candidate
PRESS RELEASE published on 08/30/2023 at 07:30, 3 years 1 month ago Formycon reports successful first half of 2023
PRESS RELEASE published on 08/29/2023 at 07:30, 3 years 1 month ago Formycon announces File Acceptance for FYB203, a biosimilar candidate to Eylea®1 (aflibercept), by the U.S. Food and Drug Administration (FDA)
PRESS RELEASE published on 08/23/2023 at 07:30, 3 years 1 month ago Formycon hosts conference call on financial and earnings position for H1 2023
PRESS RELEASE published on 08/21/2023 at 13:42, 3 years 1 month ago Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 08/07/2023 at 08:00, 3 years 1 month ago Formycon and Fresenius Kabi secure U.S. License Date for proposed Ustekinumab Biosimilar
PRESS RELEASE published on 07/26/2023 at 07:30, 3 years 2 months ago Formycon reports on the regular Annual General Meeting
Published on 10/05/2026 at 14:45, 6 hours 19 minutes ago NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
Published on 10/05/2026 at 14:30, 6 hours 34 minutes ago Hillcrest and Equipmake Expand Partnership Talks to Include Commercial Licensing of ZVS Technology
Published on 10/05/2026 at 14:30, 6 hours 34 minutes ago Solitario CEO to Present at John Tumazos Very Independent Research, LLC
Published on 10/05/2026 at 14:00, 7 hours 4 minutes ago Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth
Published on 10/05/2026 at 14:00, 7 hours 4 minutes ago GameSquare to Present at Upcoming Investor Conferences
Published on 10/05/2026 at 20:15, 49 minutes ago EQS-Adhoc: United Internet AG participates in capital increase against contributions in kind at 1&1 AG
Published on 10/05/2026 at 20:09, 55 minutes ago EQS-Adhoc: 1&1 AG resolves capital increase from authorized capital in exchange for a contribution in kind by United Internet AG
Published on 10/05/2026 at 19:30, 1 hour 34 minutes ago EEII AG: Suspension of the Jubin Frères SA Reverse Takeover
Published on 10/05/2026 at 19:00, 2 hours 4 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 28 septembre 2026 au 02 octobre 2026
Published on 10/05/2026 at 18:13, 2 hours 51 minutes ago Disclosure of shares outstanding and voting rights - 05.10.2026
Published on 10/05/2026 at 18:13, 2 hours 51 minutes ago Déclaration nombre d'actions et droits de vote - 05.10.2026
Published on 10/05/2026 at 18:00, 3 hours 4 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 septembre 2026
Published on 10/05/2026 at 17:45, 3 hours 19 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 10/05/2026 at 17:45, 3 hours 19 minutes ago Declaration of voting rights at the end of September 2026